Rick Pauls
Directeur Général chez DIAMEDICA THERAPEUTICS INC.
Fortune : 392 756 $ au 31/05/2024
Profil
Rick John Pauls is currently the President, Chief Executive Officer, and Director at DiaMedica Therapeutics, Inc. He started this position in 2014.
In the past, Mr. Pauls served as an Independent Director at LED Medical Diagnostics, Inc. He was also the Managing Director at CentreStone Ventures, Inc. from 2002 to 2010.
Additionally, he held the position of Director at Orasi Medical, Inc. and Director at Apteryx Imaging, Inc. from 2008 to 2012.
Mr. Pauls was also a Principal at Ally Financial, Inc.Mr. Pauls completed his undergraduate degree at the University of Manitoba.
He also holds an MBA from the University of North Dakota.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
01/06/2024 | 68 591 ( inf% ) | 198 914 $ | 31/05/2024 | |
01/06/2024 | 66 842 ( 0,18% ) | 193 842 $ | 31/05/2024 |
Postes actifs de Rick Pauls
Sociétés | Poste | Début |
---|---|---|
DIAMEDICA THERAPEUTICS INC. | Directeur Général | 01/01/2010 |
Anciens postes connus de Rick Pauls
Sociétés | Poste | Fin |
---|---|---|
Orasi Medical, Inc.
Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Directeur/Membre du Conseil | 18/08/2012 |
CentreStone Ventures, Inc.
CentreStone Ventures, Inc. Investment ManagersFinance CentreStone Ventures Inc (CentreStone) is an independent venture capital firm founded in 2004. The firm is headquartered in Winnipeg, Manitoba. | Private Equity Investor | 31/01/2010 |
LED Medical Diagnostics, Inc. /Old/
LED Medical Diagnostics, Inc. /Old/ Medical DistributorsDistribution Services LED Medical Diagnostics, Inc. develops and markets medical screening devices. It provides detection of mucosal tissue abnormalities including malignant and pre malignant lesions to facilitate timely diagnosis and treatment based on a proprietary fluorescence visualization technology. The company was founded by Peter Whitehead in 2003 and is headquartered in Burnaby, Canada. | Directeur/Membre du Conseil | - |
APTERYX IMAGING INC. | Directeur/Membre du Conseil | - |
ALLY FINANCIAL INC. | Corporate Officer/Principal | - |
Formation de Rick Pauls
University of Manitoba | Undergraduate Degree |
University of North Dakota | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ALLY FINANCIAL INC. | Finance |
DIAMEDICA THERAPEUTICS INC. | Health Technology |
Entreprise privées | 4 |
---|---|
CentreStone Ventures, Inc.
CentreStone Ventures, Inc. Investment ManagersFinance CentreStone Ventures Inc (CentreStone) is an independent venture capital firm founded in 2004. The firm is headquartered in Winnipeg, Manitoba. | Finance |
Orasi Medical, Inc.
Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Health Services |
Apteryx Imaging, Inc.
Apteryx Imaging, Inc. Medical SpecialtiesHealth Technology Apteryx Imaging, Inc. engages in the provision of dental imaging technology software and systems. Its products include VELscope Vx, Xelis 3D Imaging Software, Imaging Cloud, Imaging Software, IC200 Intraoral Camera, 3Shape TRIOS Intraoral Scanners, RAYSCAN Alpha 3D, TUXEDO Intraoral Sensor and LED IC100 Intraoral Camera. The company was founded by Peter Whitehead on July 17, 2002 and is headquartered in Vancouver, Canada. | Health Technology |
LED Medical Diagnostics, Inc. /Old/
LED Medical Diagnostics, Inc. /Old/ Medical DistributorsDistribution Services LED Medical Diagnostics, Inc. develops and markets medical screening devices. It provides detection of mucosal tissue abnormalities including malignant and pre malignant lesions to facilitate timely diagnosis and treatment based on a proprietary fluorescence visualization technology. The company was founded by Peter Whitehead in 2003 and is headquartered in Burnaby, Canada. | Distribution Services |